TapImmune, Inc. (TPIV.OB) Sees a Large Market Opportunity for Its TAP Vaccine Technology
TapImmune Inc. is a biotech firm focused on increasing the efficacy of vaccines by enhancing antigen presentation through the use of the Transporter of Antigen Processing (TAP). The company's technology has broad applications in developing therapeutic and preventative vaccines. TapImmune's strategy is to build a patented proprietary product pipeline and capitalize on the breadth of the TAP technology through collaborative partnerships and license agreements. The global vaccine market is estimated to be a $21 billion market in 2010. TapImmune sees large market opportunities for their TAP vaccine technology in the areas of prevention and treatment of infectious diseases and cancer.…